{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T15:49:41Z","timestamp":1790005781754,"version":"4.0.1"},"reference-count":72,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,5,12]],"date-time":"2021-05-12T00:00:00Z","timestamp":1620777600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,5,12]],"date-time":"2021-05-12T00:00:00Z","timestamp":1620777600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000265","name":"RCUK | Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000832","name":"Dowager Countess Eleanor Peel Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000832","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Schizophr"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>It is unclear whether early psychosis in the context of cannabis use is different from psychosis without cannabis. We investigated this issue by examining whether abnormalities in oculomotor control differ between patients with psychosis with and without a history of cannabis use. We studied four groups: patients in the early phase of psychosis with a history of cannabis use (EPC; <jats:italic>n<\/jats:italic>\u2009=\u200928); patients in the early phase of psychosis without (EPNC; <jats:italic>n<\/jats:italic>\u2009=\u200925); controls with a history of cannabis use (HCC; <jats:italic>n<\/jats:italic>\u2009=\u200916); and controls without (HCNC; <jats:italic>n<\/jats:italic>\u2009=\u200922). We studied smooth pursuit eye movements using a stimulus with sinusoidal waveform at three target frequencies (0.2, 0.4 and 0.6\u2009Hz). Participants also performed 40 antisaccade trials. There were no differences between the EPC and EPNC groups in diagnosis, symptom severity or level of functioning. We found evidence for a cannabis effect (<jats:italic>\u03c7<\/jats:italic><jats:sup>2<\/jats:sup>\u2009=\u200923.14, <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001), patient effect (<jats:italic>\u03c7<\/jats:italic><jats:sup>2<\/jats:sup>\u2009=\u20094.84, <jats:italic>p<\/jats:italic>\u2009=\u20090.028) and patient\u2009\u00d7\u2009cannabis effect (<jats:italic>\u03c7<\/jats:italic><jats:sup>2<\/jats:sup>\u2009=\u20094.20, <jats:italic>p<\/jats:italic>\u2009=\u20090.04) for smooth pursuit velocity gain. There was a large difference between EPC and EPNC (<jats:italic>g<\/jats:italic>\u2009=\u20090.76\u20130.86) with impairment in the non cannabis using group. We found no significant effect for antisaccade error whereas patients had fewer valid trials compared to controls. These data indicate that impairment of smooth pursuit in psychosis is more severe in patients without a history of cannabis use. This is consistent with the notion that the severity of neurobiological alterations in psychosis is lower in patients whose illness developed in the context of cannabis use.<\/jats:p>","DOI":"10.1038\/s41537-021-00155-2","type":"journal-article","created":{"date-parts":[[2021,5,12]],"date-time":"2021-05-12T10:03:45Z","timestamp":1620813825000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Eye movements in patients in early psychosis with and without a history of cannabis use"],"prefix":"10.1038","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4420-8618","authenticated-orcid":false,"given":"Musa Basseer","family":"Sami","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luciano","family":"Annibale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aisling","family":"O\u2019Neill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tracy","family":"Collier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chidimma","family":"Onyejiaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Savitha","family":"Eranti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debasis","family":"Das","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marlene","family":"Kelbrick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip","family":"McGuire","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steve C. R.","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anas","family":"Rana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrich","family":"Ettinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sagnik","family":"Bhattacharyya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,5,12]]},"reference":[{"key":"155_CR1","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1177\/0004867415599846","volume":"50","author":"H Myles","year":"2015","unstructured":"Myles, H., Myles, N. & Large, M. Cannabis use in first episode psychosis: Meta-analysis of prevalence, and the time course of initiation and continued use. Aust. N. Z. J. Psychiatry 50, 208\u2013219 (2015).","journal-title":"Aust. N. Z. J. Psychiatry"},{"key":"155_CR2","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1192\/bjp.184.2.110","volume":"184","author":"L Arseneault","year":"2004","unstructured":"Arseneault, L., Cannon, M., Witton, J. & Murray, R. M. Causal association between cannabis and psychosis: examination of the evidence. Br. J. Psychiatry 184, 110\u2013117 (2004).","journal-title":"Br. J. Psychiatry"},{"key":"155_CR3","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1016\/j.biopsych.2016.02.005","volume":"79","author":"RM Murray","year":"2016","unstructured":"Murray, R. M. & Di Forti, M. Cannabis and psychosis: what degree of proof do we require? Biol. Psychiatry 79, 514\u2013515 (2016).","journal-title":"Biol. Psychiatry"},{"key":"155_CR4","doi-asserted-by":"publisher","first-page":"54","DOI":"10.3389\/fpsyt.2014.00054","volume":"5","author":"R Radhakrishnan","year":"2014","unstructured":"Radhakrishnan, R., Wilkinson, S. T. & D\u2019Souza, D. C. Gone to pot - a review of the association between cannabis and psychosis. Front. Psychiatry 5, 54 (2014).","journal-title":"Front. Psychiatry"},{"key":"155_CR5","unstructured":"Orygen. Australian Clinical Guidelines for Early Psychosis 2nd edn (National Centre of Excellence in Youth Mental Health, 2016)."},{"key":"155_CR6","unstructured":"NICE. Psychosis And Schizophrenia in Adults: Prevention And Management CG178 (2014)."},{"key":"155_CR7","first-page":"557","volume":"35","author":"T Schoeler","year":"2016","unstructured":"Schoeler, T. et al. Association between continued cannabis use and risk of relapse in first-episode psychosis. JAMA Psychiatry 35, 557\u2013574 (2016).","journal-title":"JAMA Psychiatry"},{"key":"155_CR8","doi-asserted-by":"publisher","first-page":"e009888","DOI":"10.1136\/bmjopen-2015-009888","volume":"6","author":"R Patel","year":"2016","unstructured":"Patel, R. et al. Association of cannabis use with hospital admission and antipsychotic treatment failure in first episode psychosis: an observational study. BMJ Open 6, e009888 (2016).","journal-title":"BMJ Open"},{"key":"155_CR9","doi-asserted-by":"publisher","unstructured":"Manrique-Garcia, E. et al. Prognosis of schizophrenia in persons with and without a history of cannabis use. Psychol. Med. https:\/\/doi.org\/10.1017\/S0033291714000191 (2014).","DOI":"10.1017\/S0033291714000191"},{"key":"155_CR10","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1016\/0140-6736(93)90288-R","volume":"341","author":"JL Waddington","year":"1993","unstructured":"Waddington, J. L. Schizophrenia: developmental neuroscience and pathobiology. Lancet 341, 531\u2013536 (1993).","journal-title":"Lancet"},{"key":"155_CR11","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1093\/schbul\/sbn117","volume":"34","author":"J Van Os","year":"2008","unstructured":"Van Os, J., Rutten, B. P. F. & Poulton, R. Gene-environment interactions in schizophrenia: Review of epidemiological findings and future directions. Schizophrenia Bull. 34, 1066\u20131082 (2008).","journal-title":"Schizophrenia Bull."},{"key":"155_CR12","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1111\/acps.12847","volume":"137","author":"L Belbasis","year":"2018","unstructured":"Belbasis, L. et al. Risk factors and peripheral biomarkers for schizophrenia spectrum disorders: an umbrella review of meta-analyses. Acta Psychiatr. Scand. 137, 88\u201397 (2018).","journal-title":"Acta Psychiatr. Scand."},{"key":"155_CR13","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1038\/nrn.2017.125","volume":"18","author":"R Birnbaum","year":"2017","unstructured":"Birnbaum, R. & Weinberger, D. R. Genetic insights into the neurodevelopmental origins of schizophrenia. Nat. Rev. Neurosci. 18, 727\u2013740 (2017).","journal-title":"Nat. Rev. Neurosci."},{"key":"155_CR14","doi-asserted-by":"publisher","unstructured":"Radua, J. et al. What causes psychosis? An umbrella review of risk and protective factors. https:\/\/doi.org\/10.1002\/wps.20490 (2018).","DOI":"10.1002\/wps.20490"},{"key":"155_CR15","first-page":"159","volume":"5","author":"E-M L\u00f8berg","year":"2014","unstructured":"L\u00f8berg, E.-M. et al. The cannabis pathway to non-affective psychosis may reflect less neurobiological vulnerability. Front. Psychiatry 5, 159 (2014).","journal-title":"Front. Psychiatry"},{"key":"155_CR16","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1038\/mp.2014.51","volume":"19","author":"RA Power","year":"2014","unstructured":"Power, R. A. et al. Genetic predisposition to schizophrenia associated with increased use of cannabis. Mol. Psychiatry 19, 1201\u20131204 (2014).","journal-title":"Mol. Psychiatry"},{"key":"155_CR17","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1038\/npp.2015.251","volume":"41","author":"M Haney","year":"2016","unstructured":"Haney, M. & Evins, A. E. Does cannabis cause, exacerbate or ameliorate psychiatric disorders? An oversimplified debate discussed. Neuropsychopharmacology 41, 393\u2013401 (2016).","journal-title":"Neuropsychopharmacology"},{"key":"155_CR18","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1017\/S0033291717001209","volume":"48","author":"M Aas","year":"2018","unstructured":"Aas, M. et al. Psychotic patients who used cannabis frequently before illness onset have higher genetic predisposition to schizophrenia than those who did not. Psychol. Med. 48, 43\u201349 (2018).","journal-title":"Psychol. Med."},{"key":"155_CR19","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1093\/brain\/31.3.451","volume":"31","author":"AR Diefendorf","year":"1908","unstructured":"Diefendorf, A. R. & Dodge, R. An experimental study of the ocular reactions of the insane from photographic records. Brain 31, 451\u2013489 (1908).","journal-title":"Brain"},{"key":"155_CR20","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1001\/archpsyc.1974.01760140005001","volume":"31","author":"PS Holzman","year":"1974","unstructured":"Holzman, P. S. et al. Eye-tracking dysfunctions in schizophrenic patients and their relatives. Arch. Gen. Psychiatry 31, 143\u2013151 (1974).","journal-title":"Arch. Gen. Psychiatry"},{"key":"155_CR21","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.bandc.2008.08.012","volume":"68","author":"C Klein","year":"2008","unstructured":"Klein, C. & Ettinger, U. A hundred years of eye movement research in psychiatry. Brain Cogn. 68, 215\u2013218 (2008).","journal-title":"Brain Cogn."},{"key":"155_CR22","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1016\/j.biopsych.2012.04.019","volume":"72","author":"PJ Benson","year":"2012","unstructured":"Benson, P. J. et al. Simple viewing tests can detect eye movement abnormalities that distinguish schizophrenia cases from controls with exceptional accuracy. Biol. Psychiatry 72, 716\u2013724 (2012).","journal-title":"Biol. Psychiatry"},{"key":"155_CR23","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1007\/s00406-008-0806-y","volume":"258","author":"HM Haraldsson","year":"2008","unstructured":"Haraldsson, H. M. et al. Eye movement deficits in schizophrenia. Eur. Arch. Psychiatry Clin. Neurosci. 258, 373\u2013383 (2008).","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"key":"155_CR24","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1016\/j.bandc.2008.08.023","volume":"68","author":"GA O\u2019Driscoll","year":"2008","unstructured":"O\u2019Driscoll, G. A. & Callahan, B. L. Smooth pursuit in schizophrenia: A meta-analytic review of research since 1993. Brain Cogn. 68, 359\u2013370 (2008).","journal-title":"Brain Cogn."},{"key":"155_CR25","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.eurpsy.2008.08.003","volume":"24","author":"D Kallimani","year":"2009","unstructured":"Kallimani, D. et al. The effect of change in clinical state on eye movement dysfunction in schizophrenia. Eur. Psychiatry 24, 17\u201326 (2009).","journal-title":"Eur. Psychiatry"},{"key":"155_CR26","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1007\/BF02190739","volume":"245","author":"R Schlenker","year":"1995","unstructured":"Schlenker, R. & Cohen, R. Smooth-pursuit eye-movement dysfunction and motor control in schizophrenia: a follow-up study. Eur. Arch. Psychiatry Clin. Neurosci. 245, 125\u2013126 (1995).","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"key":"155_CR27","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1016\/0042-6989(78)90218-3","volume":"18","author":"PE Hallett","year":"1978","unstructured":"Hallett, P. E. Primary and secondary saccades to goals defined by instructions. Vis. Res. 18, 1279\u20131296 (1978).","journal-title":"Vis. Res."},{"key":"155_CR28","doi-asserted-by":"publisher","DOI":"10.1038\/tp.2017.210","volume":"7","author":"R Lencer","year":"2017","unstructured":"Lencer, R. et al. Genome-wide association studies of smooth pursuit and antisaccade eye movements in psychotic disorders: findings from the B-SNIP study. Transl. Psychiatry 7, e1249 (2017).","journal-title":"Transl. Psychiatry"},{"key":"155_CR29","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.schres.2014.12.016","volume":"163","author":"AD Radant","year":"2015","unstructured":"Radant, A. D. et al. Robust differences in antisaccade performance exist between COGS schizophrenia cases and controls regardless of recruitment strategies. Schizophr. Res. 163, 47\u201352 (2015).","journal-title":"Schizophr. Res."},{"key":"155_CR30","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1093\/schbul\/sbt132","volume":"40","author":"JL Reilly","year":"2014","unstructured":"Reilly, J. L. et al. Elevated antisaccade error rate as an intermediate phenotype for psychosis across diagnostic categories. Schizophr. Bull. 40, 1011\u20131021 (2014).","journal-title":"Schizophr. Bull."},{"key":"155_CR31","doi-asserted-by":"publisher","first-page":"1918","DOI":"10.1176\/ajp.161.10.1918","volume":"161","author":"U Ettinger","year":"2004","unstructured":"Ettinger, U. et al. Volumetric neural correlates of antisaccade eye movements in first-episode psychosis. Am. J. Psychiatry 161, 1918\u20131921 (2004).","journal-title":"Am. J. Psychiatry"},{"key":"155_CR32","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1111\/psyp.12592","volume":"53","author":"I Meyh\u00f6fer","year":"2016","unstructured":"Meyh\u00f6fer, I., Bertsch, K., Esser, M. & Ettinger, U. Variance in saccadic eye movements reflects stable traits. Psychophysiology 53, 566\u2013578 (2016).","journal-title":"Psychophysiology"},{"key":"155_CR33","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1016\/S0091-3057(97)00386-9","volume":"60","author":"RV Fant","year":"1998","unstructured":"Fant, R. V., Heishman, S. J., Bunker, E. B. & Pickworth, W. B. Acute and residual effects of marijuana in humans. Pharmacol. Biochem. Behav. 60, 777\u2013784 (1998).","journal-title":"Pharmacol. Biochem. Behav."},{"key":"155_CR34","doi-asserted-by":"publisher","first-page":"1697","DOI":"10.1177\/0269881109358200","volume":"24","author":"M Liem-Moolenaar","year":"2010","unstructured":"Liem-Moolenaar, M. et al. Central nervous system effects of haloperidol on THC in healthy male volunteers. J. Psychopharmacol. 24, 1697\u20131708 (2010).","journal-title":"J. Psychopharmacol."},{"key":"155_CR35","first-page":"18","volume":"50","author":"RW Baloh","year":"1979","unstructured":"Baloh, R. W., Sharma, S., Moskowitz, H. & Griffith, R. Effect of alcohol and marijuana on eye movements. Aviat. Space Environ. Med. 50, 18\u201323 (1979).","journal-title":"Aviat. Space Environ. Med."},{"key":"155_CR36","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1177\/0269881110376687","volume":"25","author":"GJH Dumont","year":"2011","unstructured":"Dumont, G. J. H. et al. Acute psychomotor, memory and subjective effects of MDMA and THC co-administration over time in healthy volunteers. J. Psychopharmacol. 25, 478\u2013489 (2011).","journal-title":"J. Psychopharmacol."},{"key":"155_CR37","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1177\/0269881108089581","volume":"22","author":"L Zuurman","year":"2008","unstructured":"Zuurman, L. et al. Effect of intrapulmonary tetrahydrocannabinol administration in humans. J. Psychopharmacol. 22, 707\u2013716 (2008).","journal-title":"J. Psychopharmacol."},{"key":"155_CR38","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/0920-9964(92)90005-P","volume":"6","author":"AD Radant","year":"1992","unstructured":"Radant, A. D. & Hommer, D. W. A quantitative analysis of saccades and smooth pursuit during visual pursuit tracking. A comparison of schizophrenics with normals and substance abusing controls. Schizophr. Res. 6, 225\u2013235 (1992).","journal-title":"Schizophr. Res."},{"key":"155_CR39","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1093\/cercor\/12.10.1016","volume":"12","author":"CJ Ploner","year":"2002","unstructured":"Ploner, C. J. et al. Oculomotor effects of \u03b4-9-tetrahydrocannabinol in humans: Implications for the functional neuroanatomy of the brain cannabinoid system. Cereb. Cortex 12, 1016\u20131023 (2002).","journal-title":"Cereb. Cortex"},{"key":"155_CR40","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1177\/0269881108091601","volume":"23","author":"H L.","year":"2009","unstructured":"L., H., R., R. & H.J., K. Long-term effects of cannabis on oculomotor function in humans. J. Psychopharmacol. 23, 714\u2013722 (2009).","journal-title":"J. Psychopharmacol."},{"key":"155_CR41","first-page":"267","volume":"32","author":"PJ Benson","year":"2007","unstructured":"Benson, P. J., Leonards, U., Lothian, R. M., St. Clair, D. M. & Merlo, M. C. G. Visual scan paths in first-episode schizophrenia and cannabis-induced psychosis. J. Psychiatry Neurosci. 32, 267\u2013274 (2007).","journal-title":"J. Psychiatry Neurosci."},{"key":"155_CR42","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1016\/j.psychres.2017.06.013","volume":"256","author":"S Caldani","year":"2017","unstructured":"Caldani, S. et al. Oculomotricity and Neurological Soft Signs: can we refine the endophenotype? A study in subjects belonging to the spectrum of schizophrenia. Psychiatry Res. 256, 490\u2013497 (2017).","journal-title":"Psychiatry Res."},{"key":"155_CR43","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1016\/j.schres.2015.09.032","volume":"169","author":"R Lencer","year":"2015","unstructured":"Lencer, R. et al. Pursuit eye movements as an intermediate phenotype across psychotic disorders: evidence from the B-SNIP study. Schizophr. Res. 169, 326\u2013333 (2015).","journal-title":"Schizophr. Res."},{"key":"155_CR44","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1111\/j.1469-8986.2006.00403.x","volume":"43","author":"SB Hutton","year":"2006","unstructured":"Hutton, S. B. & Ettinger, U. The antisaccade task as a research tool in psychopathology: a critical review. Psychophysiology 43, 302\u2013313 (2006).","journal-title":"Psychophysiology"},{"key":"155_CR45","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.concog.2016.10.008","volume":"48","author":"V Kumari","year":"2017","unstructured":"Kumari, V. et al. The mindful eye: smooth pursuit and saccadic eye movements in meditators and non-meditators. Conscious. Cogn. 48, 66\u201375 (2017).","journal-title":"Conscious. Cogn."},{"key":"155_CR46","first-page":"1","volume":"10","author":"T Schoeler","year":"2015","unstructured":"Schoeler, T., Kambeitz, J. & Bhattacharyya, S. The effect of cannabis on memory function in users with and without a psychotic disorder: a meta-analysis. Psychol. Med. 10, 1\u201312 (2015).","journal-title":"Psychol. Med."},{"key":"155_CR47","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1017\/S0033291711001656","volume":"42","author":"JH Meijer","year":"2012","unstructured":"Meijer, J. H. et al. Cannabis and cognitive performance in psychosis: a cross-sectional study in patients with non-affective psychotic illness and their unaffected siblings. Psychol. Med. 42, 705\u2013716 (2012).","journal-title":"Psychol. Med."},{"key":"155_CR48","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/S2215-0366(15)00363-6","volume":"3","author":"T Schoeler","year":"2016","unstructured":"Schoeler, T. et al. Continued versus discontinued cannabis use in patients with psychosis: a systematic review and meta-analysis. Lancet Psychiatry 3, 215\u2013225 (2016).","journal-title":"Lancet Psychiatry"},{"key":"155_CR49","doi-asserted-by":"publisher","unstructured":"Sami, M. B. & Bhattacharyya, S. Are cannabis-using and non-using patients different groups? Towards understanding the neurobiology of cannabis use in psychotic disorders. J. Psychopharmacol. https:\/\/doi.org\/10.1177\/0269881118760662 (2018).","DOI":"10.1177\/0269881118760662"},{"key":"155_CR50","doi-asserted-by":"publisher","unstructured":"Steffens, M. et al. Effects of ketamine on brain function during smooth pursuit eye movements. Hum. Brain Mapp. https:\/\/doi.org\/10.1002\/hbm.23294 (2016).","DOI":"10.1002\/hbm.23294"},{"key":"155_CR51","doi-asserted-by":"publisher","unstructured":"Steffens, M. et al. Effects of ketamine on brain function during response inhibition. Psychopharmacology https:\/\/doi.org\/10.1007\/s00213-018-5081-7 (2018).","DOI":"10.1007\/s00213-018-5081-7"},{"key":"155_CR52","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/j.bandc.2008.08.021","volume":"68","author":"SB Hutton","year":"2008","unstructured":"Hutton, S. B. Cognitive control of saccadic eye movements. Brain Cogn. 68, 327\u2013340 (2008).","journal-title":"Brain Cogn."},{"key":"155_CR53","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.bandc.2008.08.020","volume":"68","author":"GR Barnes","year":"2008","unstructured":"Barnes, G. R. Cognitive processes involved in smooth pursuit eye movements. Brain Cogn. 68, 309\u2013326 (2008).","journal-title":"Brain Cogn."},{"key":"155_CR54","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1002\/(SICI)1097-0193(1999)8:4<209::AID-HBM5>3.0.CO;2-0","volume":"8","author":"RA Berman","year":"1999","unstructured":"Berman, R. A. et al. Cortical networks subserving pursuit and saccadic eye movements in humans: An FMRI study. Hum. Brain Mapp. 8, 209\u2013225 (1999).","journal-title":"Hum. Brain Mapp."},{"key":"155_CR55","doi-asserted-by":"crossref","unstructured":"Sweeney, J. A., Luna, B., Keedy, S. K., McDowell, J. E. & Clementz, B. A. fMRI studies of eye movement control: investigating the interaction of cognitive and sensorimotor brain systems. NeuroImage 36, T54\u2013T60 (2007).","DOI":"10.1016\/j.neuroimage.2007.03.018"},{"key":"155_CR56","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.neuropharm.2017.06.018","volume":"124","author":"RM Murray","year":"2017","unstructured":"Murray, R. M. et al. Cannabis-associated psychosis: neural substrate and clinical impact. Neuropharmacology 124, 89\u2013104 (2017).","journal-title":"Neuropharmacology"},{"key":"155_CR57","doi-asserted-by":"publisher","first-page":"5070","DOI":"10.2174\/138161212802884861","volume":"18","author":"C Rapp","year":"2012","unstructured":"Rapp, C., Bugra, H., Riecher-R\u00f6ssler, A., Tamagni, C. & Borgwardt, S. Effects of cannabis use on human brain structure in psychosis: a systematic review combining in vivo structural neuroimaging and post mortem studies. Curr. Pharm. Des. 18, 5070\u20135080 (2012).","journal-title":"Curr. Pharm. Des."},{"key":"155_CR58","doi-asserted-by":"publisher","unstructured":"Sami, M., Notley, C., Kouimtsidis, C., Lynskey, M. & Bhattacharyya, S. Psychotic-like experiences with cannabis use predict cannabis cessation and desire to quit: a cannabis discontinuation hypothesis. Psychol. Med. https:\/\/doi.org\/10.1017\/S0033291718000569 (2018).","DOI":"10.1017\/S0033291718000569"},{"key":"155_CR59","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1177\/0269881116675511","volume":"31","author":"I Meyh\u00f6fer","year":"2017","unstructured":"Meyh\u00f6fer, I., Kumari, V., Hill, A., Petrovsky, N. & Ettinger, U. Sleep deprivation as an experimental model system for psychosis: effects on smooth pursuit, prosaccades, and antisaccades. J. Psychopharmacol. 31, 418\u2013433 (2017).","journal-title":"J. Psychopharmacol."},{"key":"155_CR60","doi-asserted-by":"publisher","first-page":"1755","DOI":"10.1111\/psyp.12917","volume":"54","author":"I Meyh\u00f6fer","year":"2017","unstructured":"Meyh\u00f6fer, I. et al. Combining two model systems of psychosis: the effects of schizotypy and sleep deprivation on oculomotor control and psychotomimetic states. Psychophysiology 54, 1755\u20131769 (2017).","journal-title":"Psychophysiology"},{"key":"155_CR61","doi-asserted-by":"publisher","unstructured":"Meyh\u00f6fer, I., Kasparbauer, A. M., Steffens, M. & Ettinger, U. Effects of nicotine on smooth pursuit eye movements in healthy non-smokers. Psychopharmacology https:\/\/doi.org\/10.1007\/s00213-019-05223-1 (2019).","DOI":"10.1007\/s00213-019-05223-1"},{"key":"155_CR62","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1093\/schbul\/sbr136","volume":"38","author":"BA Cornblatt","year":"2012","unstructured":"Cornblatt, B. A. et al. Risk factors for psychosis: Impaired social and role functioning. Schizophr. Bull. 38, 1247\u20131257 (2012).","journal-title":"Schizophr. Bull."},{"key":"155_CR63","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1080\/09602011.2016.1231121","volume":"28","author":"P Bright","year":"2018","unstructured":"Bright, P., Hale, E., Gooch, V. J., Myhill, T. & van der Linde, I. The National Adult Reading Test: restandardisation against the Wechsler Adult Intelligence Scale-Fourth edition. Neuropsychol. Rehabil. 28, 1019\u20131027 (2018).","journal-title":"Neuropsychol. Rehabil."},{"key":"155_CR64","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1111\/j.1360-0443.1991.tb01879.x","volume":"86","author":"TF Heatherton","year":"1991","unstructured":"Heatherton, T. F., Kozlowski, L. T., Frecker, R. C. & Fagerstr\u00f6m, K. O. The fagerstr\u00f6m test for nicotine dependence: a revision of the fagerstr\u00f6m tolerance questionnaire. Br. J. Addict. 86, 1119\u20131127 (1991).","journal-title":"Br. J. Addict."},{"key":"155_CR65","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1046\/j.1360-0443.1995.9056072.x","volume":"90","author":"M Gossop","year":"1995","unstructured":"Gossop, M. et al. The severity of dependence scale (SDS): Psychometric properties of the SDS in English and Australian samples of heroin, cocaine and amphetamine users. Addiction 90, 607\u2013614 (1995).","journal-title":"Addiction"},{"key":"155_CR66","unstructured":"Sobell, L. C. & Sobell, M. B. Timeline Followback user\u2019s guide: a calendar method for assessing alcohol and drug use. Toronto Addiction Res. Found (Addiction Research Foundation, Toronto 1996)."},{"key":"155_CR67","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1159\/000092678","volume":"39","author":"EJ Barkus","year":"2006","unstructured":"Barkus, E. J., Stirling, J., Hopkins, R. S. & Lewis, S. Cannabis-induced psychosis-like experiences are associated with high schizotypy. Psychopathology 39, 175\u2013178 (2006).","journal-title":"Psychopathology"},{"key":"155_CR68","first-page":"1","volume":"0366","author":"T Schoeler","year":"2016","unstructured":"Schoeler, T. et al. Effects of continuation, frequency and type of cannabis use on relapse in the first two years following onset of psychosis - an observational study. Lancet Psychiatry 0366, 1\u20137 (2016).","journal-title":"Lancet Psychiatry"},{"key":"155_CR69","unstructured":"Taylor, D., Paton, C. & Kapur, S. The Maudsley Prescribing Guidelines. The South London and Maudsley NHS Foundation Trust and the OXLEAS NHS Foundation Trust (CRC Press, 2016)."},{"key":"155_CR70","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1176\/appi.ajp.2009.09060802","volume":"167","author":"DM Gardner","year":"2010","unstructured":"Gardner, D. M., Murphy, A. L., O\u2019Donnell, H., Centorrino, F. & Baldessarini, R. J. International consensus study of antipsychotic dosing. Am. J. Psychiatry 167, 686\u2013693 (2010).","journal-title":"Am. J. Psychiatry"},{"key":"155_CR71","doi-asserted-by":"crossref","unstructured":"Bates, D., M\u00e4chler, M., Bolker, B. M. & Walker, S. C. Fitting linear mixed-effects models using lme4. J. Stat. Softw. 67, 1\u201348 (2015).","DOI":"10.18637\/jss.v067.i01"},{"key":"155_CR72","doi-asserted-by":"crossref","unstructured":"Singmann, H. & Kellen, D. New Methods in Cognitive Psychology p. 4\u201331 (Taylor & Francis, 2019).","DOI":"10.4324\/9780429318405-2"}],"container-title":["npj Schizophrenia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41537-021-00155-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41537-021-00155-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41537-021-00155-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,2]],"date-time":"2022-12-02T23:20:57Z","timestamp":1670023257000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41537-021-00155-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,12]]},"references-count":72,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["155"],"URL":"https:\/\/doi.org\/10.1038\/s41537-021-00155-2","relation":{},"ISSN":["2334-265X"],"issn-type":[{"value":"2334-265X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,12]]},"assertion":[{"value":"21 November 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 April 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 May 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"24"}}